This project will examine the beneficial effects of growth hormone and IGF-I in AIDS patients who are wasting. Ninety-five percent of this project is funded by Genetech, Inc. However, they have refused to pay for some ancillary studies which they feel are not necessary for FDA drug approval.
Showing the most recent 10 out of 568 publications